Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 760-766

  Almqvist, Erik G ^a   Becker, Charlotte ^b   Bondeson, Anne Greth ^b   Bondeson, Lennart ^b   Svensson, Johan ^a   Svensson, Sven Eric ^c  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BLEKINGE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCIUM; CREATININE; ESTRADIOL; N TERMINAL PRO B TYPE NATRIURETIC PEPTIDE; PARATHYROID HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLE; EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTHYROIDISM; KIDNEY FUNCTION; MALE; PARATHYROID DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK ASSESSMENT; SYSTOLE; TESTOSTERONE BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CALCIUM; CREATININE; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PARATHYROID HORMONE; PARATHYROIDECTOMY; PEPTIDE FRAGMENTS; SEX HORMONE-BINDING GLOBULIN; STROKE VOLUME; TESTOSTERONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33751074669     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02663.x     Document Type: Article

References (42)

1. Ronni-Sivula, H. (1985) Causes of death in patients previously operated on for primary hyperparathyroidism. Annales Chirurgiae et Gynaecologiae, 74, 13-18.
2. Palmér, M., Adami, H.O., Bergström, R., Åkerström, G. & Ljunghall, S. (1987) Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery, 102, 1-7.
3. Hedbäck, G., Tisell, L.E., Bengtsson, B.Å., Hedman, I. & Odén, A. (1990) Premature death in patients operated on for primary hyperparathyroidism. World Journal of Surgery, 14, 829-836.
4. Andersson, P., Rydberg, E. & Willenheimer, R. (2004) Primary hyperparathyroidism and heart disease - a review. European Heart Journal, 25, 1776-1787.
5. Smogorzewski, M., Zayed, M., Zhang, Y.B., Roe, J. & Massry, S.G. (1993) Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. American Journal of Physiology: Heart and Circulatory Physiology, 264, H1998-H2006.
6. NIH conference. (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Annals of Internal Medicine, 114, 593-597.
7. Bilezikian, J.P., Potts, J.T., Fuleihan, G.H., Kleerekoper, M., Neer, R., Peacock, M., Rastad, J., Silverberg, S.J., Udelsman, R. & Wells, S.A. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. Journal of Clinical Endocrinology and Metabolism, 87, 5353-5361.
8. Almqvist, E.G., Bondeson, A.G., Bondeson, L., Nissborg, A., Smedgård, P. & Svensson, S.E. (2002) Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery, 132, 1126-1132.
9. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B. & Castelli, W.P. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. New England Journal of Medicine, 322, 1561-1566.
10. Koren, M.J., Devereux, R.B., Casale, P.N., Savage, D.D. & Laragh, J.H. (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Annals of Internal Medicine, 114, 345-352.
11. Cowie, M.R. & Mendez, G.F. (2002) BNP and congestive heart failure. Progress in Cardiovascular Disease, 44, 293-321.
12. Clerico, A. & Emdin, M. (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clinical Chemistry, 50, 33-50.
13. Ruskoaho, H. (2003) Cardiac hormones as diagnostic tools in heart failure. Endocrine Reviews, 24, 341-356.
14. Alibay, Y., Beauchet, A., Mahmoud, R.E., Brun-Ney, D., Alexandre, J.A., Benoit, M.O., Dubourg, O., Aegerter, P., Boileau, C., Jondeau, G. & Puy, H. (2004) Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea. Clinical Biochemistry, 37, 933-936.
15. Glendenning, P. (2003) Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines. Internal Medicine Journal, 33, 598-603.
16. Du Bois, D. & Du Bois, E.F. (1916) A formula to estimate the approximate surface area if height and weight be known. Archives of Internal Medicine, 17, 863-871.
17. Gennari, L., Merlotti, D., Martini, G., Gonelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C. & Nuti, R. (2003) Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. Journal of Clinical Endocrinology and Metabolism, 88, 5327-5333.
18. Wheeler, M.J. (1995) The determination of bio-available testosterone. Annals of Clinical Biochemistry, 32, 345-357.
19. Magnusson, M., Melander, O., Israelsson, B., Grubb, A., Groop, L. & Jovinge, S. (2004) Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care, 27, 1929-1935.
20. Krauser, D.G., Lloyd-Jones, D.M., Chae, C.U., Cameron, R., Anwaruddin, S., Baggish, A.L., Chen, A., Tung, R. & Januzzi, J.L. (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. American Heart Journal, 149, 744-750.
21. Wallén, T., Landahl, S., Hedner, T., Nakao, K. & Saito, Y. (1997) Brain natriuretic peptide predicts mortality in the elderly. Heart, 77, 264-267.
22. McDonagh, T.A., Cunningham, A.D., Morrison, C.E., McMurray, J.J., Ford, I., Morton, J.J. & Dargie, H.J. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart, 86, 21-26.
23. Ueda, R., Yokouchi, M., Suzuki, T., Otomo, E. & Katagiri, T. (2003) Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. American Journal of Medicine, 114, 266-270.
24. Wang, T.J., Larson, M.G., Levy, D., Benjamin, E.J., Leip, E.P., Omland, T., Wolf, P.A. & Vasan, R.S. (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. New England Journal of Medicine, 350, 655-663.
25. Groenning, B.A., Raymond, I., Hildebrandt, P.R., Nilsson, J.C., Baumann, M. & Pedersen, F. (2004) Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart, 90, 297-303.
26. Schultz, M., Faber, J., Kistorp, C., Jarløv, A., Pedersen, F., Wiinberg, N. & Hildebrandt, P. (2004) N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clinical Endocrinology, 60, 54-59.
27. Luchner, A., Burnett, J.C. Jr, Jougasaki, M., Hense, H.W., Riegger, G.A.J. & Schunkert, H. (1998) Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. Journal of the American College of Cardiology, 32, 1839-1844.
28. Goetze, J.P., Jensen, G., Møller, S., Bendtsen, F., Rehfeld, J.F. & Henriksen, J.H. (2006) BNP and N-terminal proBNP are both extracted in the normal kidney. European Journal of Clinical Investigation, 36, 8-15.
29. Yufu, K., Takahashi, N., Nakagawa, M., Hara, M., Saikawa, T. & Yoshimatsu, H. (2006) Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients. Diabetes Research and Clinical Practice, 72, 12-19.
30. Maffei, S., Del Ry, S., Prontera, C. & Clerico, A. (2001) Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clinical Science, 101, 447-453.
31. Almqvist, E.G., Becker, C., Bondeson, A.G., Bondeson, L. & Svensson, J. (2006) Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women. Clinical Endocrinology, 64, 58-62.
32. Olsen, M.H., Wachtell, K., Tuxen, C., Fossum, E., Bang, L.E., Hall, C., Ibsen, H., Rokkedal, J., Devereux, R.B. & Hildebrandt, P. (2004) N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. Journal of Hypertension, 22, 1597-1604.
33. Stefenelli, T., Abela, C., Frank, H., Koller-Strametz, J., Globits, S., Bergler-Klein, J. & Niederle, B. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. Journal of Clinical Endocrinology and Metabolism, 82, 106-112.
34. Piovesan, A., Molineri, N., Casasso, F., Emmolo, I., Ugliengo, G., Cesario, F. & Borretta, G. (1999) Left ventricular hypertrophy in primary hyperparathyroidism: effects of successful parathyroidectomy. Clinical Endocrinology, 50, 321-328.
35. Redfield, M.M., Rodeheffer, R.J., Jacobsen, S.J., Mahoney, D.W., Bailey, K.R. & Burnett, J.C. Jr (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. Journal of the American College of Cardiology, 40, 976-982.
36. Vasan, R.S., Benjamin, E.J., Larson, M.G., Leip, E.P., Wang, T.J., Wilson, P.W. & Levy, D. (2002) Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. Journal of the American Medical Association, 288, 1252-1259.
37. Øgard, C.G., Engelmann, M.D., Kistorp, C., Nielsen, S.L. & Vestergaard, H. (2005) Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clinical Endocrinology, 63, 493-498.
38. Sokoll, L.J., Baum, H., Collinson, P.O., Gurr, E., Haass, M., Luthe, H., Morton, J.J., Nowatzke, W. & Zingler, C. (2004) Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clinical Chemistry and Laboratory Medicine, 42, 965-972.
39. Nilsson, I.L., Åberg, J., Rastad, J. & Lind, L. (2000) Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy. Surgery, 128, 895-902.
40. Georgiannos, S.N., Jenkins, B.J. & Goode, A.W. (1996) Cardiac output in asymptomatic primary hyperparathyroidism: a stigma of early cardiovascular dysfunction. International Surgery, 81, 171-173.
41. Lang, R.M., Fellner, S.K., Neumann, A., Bushinsky, D.A. & Borow, K.M. (1988) Left ventricular contractility varies directly with blood ionized calcium. Annals of Internal Medicine, 108, 524-529.
42. Ogino, K., Burkhoff, D. & Bilezikian, J.P. (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology, 136, 3024-3030.